輸入代號或公司名稱後按 Enter
NVCR

NovoCure Ltd

+0.56 (+3.45%)前一交易日收盤 2026-09-17
美股 · Nasdaq · 醫療器材 · 外科與醫療器材SIC 3841
16.78USD325K成交股數2.0B市值本益比(近四季)2.8股價營收比+15.6%營收年增(近四季)2026-10-29下次財報

財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束

逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。

營收與利潤率近 16 季

稀釋 EPS近 16 季 · 美元

現金流近 16 季

股東回饋近 16 季 · 庫藏股與股利

損益表 逐季 · 最新在左 · 小字是年增率

科目26Q226Q125Q325Q225Q124Q424Q324Q224Q123Q323Q223Q1
營收184M+18%174M+8%167M+8%159M+6%155M+12%161M+27%155M+23%150M+23%139M127M126M122M
營業成本41.1M38.9M44.7M41.5M38.5M33.5M35.4M34.7M33.7M32.1M34.0M29.6M
毛利142M+22%135M+6%122M+2%117M+1%116M+11%128M+34%120M+30%116M+25%105M95.2M92.0M92.6M
毛利率77.6%77.6%73.2%73.9%75.1%79.2%77.2%77.0%75.7%74.8%73.0%75.8%
研發費用51.4M58.3M54.0M55.8M53.8M51.2M51.9M55.0M51.6M53.6M55.4M59.7M
銷售管理費用39.9M85.9M45.9M44.0M44.8M72.5M40.1M37.7M39.5M41.9M40.8M41.9M
營業利益−10.6M-72%−67.4M+7%−36.0M+12%−39.5M+18%−37.9M-9%−63.3M+9%−32.1M-49%−33.6M-44%−41.5M−58.2M−62.7M−60.2M
營業利益率-5.8%-38.7%-21.5%-24.9%-24.4%-39.3%-20.7%-22.3%-30.0%-45.7%-49.7%-49.3%
稅後淨利−15.7M-54%−71.1M+7%−37.3M+22%−40.1M+20%−34.3M-11%−66.3M+34%−30.6M-47%−33.4M-37%−38.8M−49.5M−57.4M−53.1M
淨利率-8.5%-40.9%-22.3%-25.3%-22.1%-41.1%-19.7%-22.2%-28.0%-38.9%-45.6%-43.4%
稀釋 EPS-0.13-58%-0.62+2%-0.33+18%-0.36+16%-0.31-14%-0.61+33%-0.28-48%-0.31-38%-0.36-0.46-0.54-0.50
稀釋股數116M114M112M112M110M108M108M108M107M107M106M106M

資產負債表 期末餘額

科目26Q226Q125Q325Q225Q124Q424Q324Q224Q123Q323Q223Q1
現金與約當現金93.7M87.5M342M150M127M164M185M165M454M155M157M186M
應收帳款99.1M93.3M85.2M89.9M84.5M74.2M67.1M64.7M65.1M65.1M71.0M74.8M
存貨42.2M43.5M39.1M40.2M39.5M35.1M39.1M40.4M42.4M36.8M33.0M31.7M
總資產795M788M1.4B1.2B1.2B1.2B1.2B1.2B1.1B1.1B1.2B1.2B
有息負債97.3M570M568M567M566M
總負債457M457M1.0B896M887M881M861M850M762M753M743M742M
股東權益338M331M341M349M362M360M361M362M359M394M416M432M
負債比57.5%58.0%74.9%72.0%71.0%71.0%70.5%70.2%68.0%65.7%64.1%63.2%
淨現金(現金 − 有息負債)66.5M−116M−413M−410M−380M

現金流量表 單季

科目26Q226Q125Q325Q225Q124Q424Q324Q224Q123Q323Q223Q1
營業現金流8.1M-123%−13.5M+292%20.6M+98%−15.9M+827%−35.7M+13%−3.5M-82%10.4M-146%−1.7M-90%−31.6M−19.3M−22.7M−16.7M
資本支出6.9M5.2M5.7M5.5M10.6M8.9M10.7M11.4M11.8M7.3M6.9M6.1M
自由現金流1.2M-103%−18.7M+51%14.9M-4960%−21.4M+63%−46.3M+7%−12.4M-53%−307K-99%−13.2M-42%−43.4M−26.6M−29.7M−22.8M
折舊攤銷4.3M4.1M3.7M3.4M3.3M3.1M2.5M2.9M2.8M2.8M2.7M2.7M
買回庫藏股
現金股利
自由現金流率0.7%-10.7%8.9%-13.5%-29.9%-7.7%-0.2%-8.8%-31.3%-20.9%-23.5%-18.7%

營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度

地區2025 年度 · 387M
International Markets250M64.7%+27.7%
德國79.4M20.5%+21.7%
日本37.8M9.8%+16.0%
中國19.4M5.0%+11.8%
美國 小計386M99.7%-1.6%
法國 小計76.2M19.7%+36.7%
Other International Markets 小計56.9M14.7%+34.0%

各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。

年度 10-K

財年營收年增稅後淨利淨利率稀釋 EPS自由現金流
FY2025655M+8.3%−136M-20.8%-1.22−75.7M
FY2024605M+18.8%−169M-27.9%-1.56−69.2M
FY2023509M-5.3%−207M-40.6%-1.95−100M
FY2022538M+0.5%−93.0M-17.3%-0.889.4M
FY2021535M+8.2%−58.0M-10.8%-0.5658.6M
FY2020494M+40.7%19.8M4.0%0.1884.2M
FY2019351M+41.6%−7.2M-2.1%-0.0716.1M
FY2018248M−63.6M-25.6%-0.69−8.6M